More importantly, LZTS1 expression is much higher in inflamed intestinal mucosa of CD patients than that of noninflamed intestinal mucosa of CD patients, suggesting that high expression of LZTS1 promotes inflammatory symptoms in CD, thus increasing the CRC risk. Here, LZTS1 is linked to colorectal carcinoma.